Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Capital Access Group – TheraCryf £1.1m raise progressing Ox-1 to clinical trial

mel | 20 August 2026

Categories:

Post navigation

← Notice of GM and Form of Proxy

Privacy Policy
Data Protection Complaints Handling Process
Sitemap

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.